Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines - Daiichi Sankyo Co (OTC:DSNKY)
Australia biotech startup Psylo has inked a sponsored research agreement with global Japanese pharmaceutical company Daiichi Sankyo (OTCMKTS: DSNKY) toward advancing antidepressant psychiatric medicines.
Source: benzinga.com